Quince Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Quince Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • Quince Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $85.1M, a 22.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $85.1M +$15.4M +22.1% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $69.7M +$11.1M +18.9% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $58.6M +$23.6M +67.3% Dec 31, 2021 10-K 2023-03-15
Q4 2020 $35M +$18.5M +112% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $16.5M +$8.55M +108% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $7.94M Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.